Austar Lifesciences Ltd. (HK:6118) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Austar Lifesciences Limited has scheduled a Board meeting on August 27, 2024, to review the Group’s unaudited financial results for the first half of the year and to consider the possibility of declaring an interim dividend. The meeting will be critical for shareholders looking to understand the company’s recent financial performance and dividend prospects.
For further insights into HK:6118 stock, check out TipRanks’ Stock Analysis page.